| CGRP | Calcitonin Gene Related Peptide(Protein) |
|---|---|
| CGRPs | Calcitonin Gene-Related Products |
| GnRH | Gonadotropin Releasing Hormone [HP 1898, 2034] = LHRH = Go... |
| ARGS | antitrypsin-related gene sequence |
| CAP | camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab... |
| leukaemic infiltration | A pathologic change in leukaemia in which leukaemic cells permeate various organs at any stage of the disease. All types of leukaemia show various degrees of infiltration, depending upon the type of leukaemia. The degree of infiltration may vary from site to site. The liver and spleen are common sites of infiltration, the greatest appearing in myelocytic leukaemia, but infiltration is seen also in the granulocytic and lymphocytic types. The kidney is also a common site and of the gastrointestinal system, the stomach and ileum are commonly involved. In lymphocytic leukaemia the skin is often infiltrated. The central nervous system too is a common site. (12 Dec 1998) |
|---|---|
| leukaemic leukaemia | A redundant term sometimes used to emphasize the occurrence of abundant numbers of leukaemic cells in the circulating blood; this classic form of leukaemia is usually termed simply leukaemia. (05 Mar 2000) |
| leukaemic myelosis | <haematology, tumour> A form of leukaemia characterised by an uncontrolled proliferation of myelopoietic cells in the bone marrow and in extramedullary sites, and the presence of large numbers of immature and mature granulocytic forms in various tissues (and organs) and in the circulating blood. The total count may range from 1000 (aleukaemic variety) to several hundred thousand per cu mm. The predominant cell is usually of the neutrophilic series, but, in a few instances, eosinophilic or basophilic granulocytes, or even megakaryocytes, may represent the chief form; early in granulocytic leukaemia, the circulating blood may contain excessive numbers of all of the granulocytic forms. Synonym: leukaemic myelosis, myelocytic leukaemia, myelogenic leukaemia, myelogenous leukaemia, myeloid leukaemia. (05 Mar 2000) |
| leukaemic reticuloendotheliosis | An obsolete term for hairy cell leukaemia. (05 Mar 2000) |
| leukaemic reticulosis | Cancer of the blood due to proliferation of cells of the monocyte series. Origin: Gr. Haima = blood (13 Nov 1997) |
| leukaemic retinitis | See: leukaemic retinopathy. (05 Mar 2000) |
| leukaemic retinopathy | Appearance of the retina in all types of leukaemia, characterised by engorgement and tortuosity of veins, scattered haemorrhages, and oedema of the retina and disk. (05 Mar 2000) |
| appetite regulation | Physiologic mechanisms which regulate or control the appetite and food intake. (12 Dec 1998) |
| regulation | 1. <biology> The adaption of form or behaviour of an organism to changed conditions. 2. <embryology> The power of a pregastrula stage to form a whole embryo from a part. Origin: L. Regula = rule (18 Nov 1997) |
| coordinate regulation | The expression of many different genes at once. (09 Oct 1997) |
| self-regulation | A three-stage strategy patients are taught to use in order to end risky health-associated behaviours such as smoking and overeating. 1. Self-monitoring (self-observation), the first stage in self-regulation involves the individual's deliberately attending to and recording his or her own behaviour; 2. Self-evaluation, the second stage, in which the individual assesses what was learned by self-monitoring, such as how often and where one smokes, and uses those observational data to establish health goals or criteria; 3. Self-reinforcement, the third stage, in which the individual rewards him/herself for each behavioural success on the road to that goal, thereby enhancing the chance of reaching it. (05 Mar 2000) |
| negative regulation | Negative feedback in biological systems mediated by allosteric regulatory enzymes. (18 Nov 1997) |
| down-regulation | <physiology> Development of a refractory or tolerant state consequent upon repeated administration of a pharmacologically or physiologically active substance. It is the process that decreases ligand and receptor interactions or reduces the responsiveness of a cell to a stimulus following first exposure. This is often accompanied by an initial decrease in affinity of receptors for the agent and a subsequent reduction in the number of available receptors expressed on the surface which can result from internalisation of the ligand:receptor complex or from decreased expression of the receptor. Classically the concept referred to hormone receptors but contemporary usage includes other cell surface receptors. (03 Jul 1999) |
| target regulation | <physiology> General term for an interaction between neurons and their targets by which target derived signals influence the differentiation of the innervating neurons. (18 Nov 1997) |
| enzyme regulation | <biochemistry> Control of the rate of a reaction catalyzed by an enzyme by some effector (e.g., inhibitors or activators) or by alteration of some condition (e.g., pH or ionic strength). (05 Mar 2000) |